Elamipretide: all 27 studies that test it

Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.

• Clinical Trial in Patients With Barth Syndrome- 4TAZPowerRecruitingNCT07531251Phase 4
• FRDA Investigator Initiated Study (IIS) With ElamipretideCompletedNCT05168774Phase 1/2Results posted
• ReCLAIM-2 Study to Evaluate Safety,Efficacy & Pharmacokinetics of Elamipretide in Subjects With AMD With Non-central GACompletedNCT03891875Phase 2Results posted
• A Trial to Evaluate Safety and Efficacy of Elamipretide Primary Mitochondrial Myopathy Followed by Open-Label ExtensionTerminatedNCT03323749Phase 3Results posted
• A Trial to Evaluate Safety, Tolerability and Efficacy of Elamipretide in Subjects With Barth SyndromeCompletedNCT03098797Phase 2/3Results posted
• Open-Label Extension Trial to Characterize the Long-term Safety and Tolerability of Elamipretide in Subjects With Genetically Confirmed Primary Mitochondrial Myopathy (PMM)TerminatedNCT02976038Phase 2Results posted
• An Open-Label, Phase 1 Clinical Study to Evaluate the Safety and Tolerability of Subcutaneous Elamipretide in Subjects With Intermediate Age-Related Macular DegenerationCompletedNCT02848313Phase 1Results posted
• Safety, Tolerability, Efficacy of MTP-131 for Treatment of Mitochondrial Disease in Subjects From the MMPOWER StudyCompletedNCT02805790Phase 2Results posted
• Effect of Elamipretide on Left Ventricular Function in Subjects With Stable Heart Failure With Reduced Ejection FractionCompletedNCT02788747Phase 2Results posted
• A Study Investigating the Safety, Tolerability, and Efficacy of Elamipretide Topical Ophthalmic Solution for Treatment of Leber's Hereditary Optic NeuropathyCompletedNCT02693119Phase 2Results posted
• Safety, Tolerability, and Efficacy of MTP-131 for the Treatment of Mitochondrial MyopathyCompletedNCT02367014Phase 1/2Results posted
• A Phase 2 Study to Evaluate the Impact of MTP-131 (Bendavia™) on Skeletal Muscle Function in ElderlyCompletedNCT02245620Phase 2Results posted
• Effects of Intravenous Bendavia™ on Reperfusion Injury in Patients Undergoing Angioplasty of the Renal ArteryTerminatedNCT01755858Phase 1/2Results posted
• Evaluation of Myocardial Effects of MTP-131 for Reducing Reperfusion Injury in Patients With Acute Coronary EventsCompletedNCT01572909Phase 2Results posted
• ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD)Active, not recruitingNCT06373731Phase 3
• Study to Evaluate Efficacy and Safety of Elamipretide in Subjects With Primary Mitochondrial Disease From Nuclear DNA Mutations (nPMD)CompletedNCT05162768Phase 3
• A Phase 2 Study to Evaluate the Cardiac and Renal Effects of Short Term Treatment With Elamipretide in Patients Hospitalized With Congestion Due to Heart FailureCompletedNCT02914665Phase 2
• A Study to Evaluate the Effects of 4 Weeks Treatment With Subcutaneous Elamipretide on Left Ventricular Function in Subjects With Stable Heart Failure With Preserved Ejection FractionCompletedNCT02814097Phase 2
• A Phase 1 Study Investigating the Safety and Pharmacokinetics of Repeat-dose Intravenous Infusion of MTP-131 in Subjects With Impaired Renal FunctionCompletedNCT02436447Phase 1
• A Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of Bendavia™ (MTP-131) in Patients With Heart FailureWithdrawnNCT02388529Phase 1
• A Study Investigating the Safety, Tolerability, and Pharmacokinetics of MTP-131 in Subjects With Congestive Heart FailureCompletedNCT02388464Phase 1
• A Study of MTP-131 Topical Ophthalmic Solution in Subjects With Diabetic Macular Edema and Non-Exudative Intermediate Age-related Macular DegenerationCompletedNCT02314299Phase 1/2
• Safety and Pharmacokinetic (PK) Study of Oral Bendavia Administered for 7 DaysCompletedNCT01786915Phase 1
• A Phase 1 Study Examining the Pharmacokinetics and Tolerability of a Single Oral Dose of Bendavia (MTP-131)CompletedNCT01754818Phase 1
• The Impact of Intravenous Bendavia™ on Endothelial Reactivity Dysfunction in Cigarette SmokingCompletedNCT01518985Phase 1
• Study to Assess the Pharmacodynamic Effects of Unfractionated Heparin (UFH) in Healthy Volunteers With and Without BendaviaCompletedNCT01513200Phase 1
• Study to Evaluate Safety, Tolerability, and Pharmacokinetics (PK) of Intravenous (IV) Infusion of MTP-131 (Bendavia™) in Healthy AdultsCompletedNCT01115920Phase 1

← Elamipretide overview